![Lucinda Hopkins-Jones](https://profiles-cardiff.imgix.net/attachments/2457?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Miss Lucinda Hopkins-Jones
Timau a rolau for Lucinda Hopkins-Jones
Rheolwr Sampl a Llywodraethiant, Is-adran Meddygaeth Seicolegol a Niwrowyddorau Clinigol
Cyhoeddiad
2023
- Winchester, L. et al., 2023. Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid. Brain Communications 5 (1) fcac343. (10.1093/braincomms/fcac343)
2022
- Warne, N. et al. 2022. Collecting genetic samples and linked mental health data from adolescents in schools: protocol co-production and a mixed-methods pilot of feasibility and acceptability. BMJ Open 12 (2) e049283. (10.1136/bmjopen-2021-049283)
2020
- Wong, H. S. et al., 2020. Pilot study to establish a prospective neonatal cohort: Study of Preterm Infants and Neurodevelopmental Genes (SPRING). Molecular Psychiatry 4 (1) e000648. (10.1136/bmjpo-2020-000648)
- Legge, S. et al. 2020. Clinical indicators of treatment-resistant psychosis. British Journal of Psychiatry 216 (5), pp.259-266. (10.1192/bjp.2019.120)
2019
- Harold, D. et al., 2019. Population-based identity-by-descent mapping combined with exome sequencing to detect rare risk variants for schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 180 (3), pp.223-231. (10.1002/ajmg.b.32716)
2017
- Cosgrove, D. et al., 2017. MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls. Translational Psychiatry 7 (1), pp.e1012. (10.1038/tp.2016.286)
Erthyglau
- Winchester, L. et al., 2023. Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid. Brain Communications 5 (1) fcac343. (10.1093/braincomms/fcac343)
- Warne, N. et al. 2022. Collecting genetic samples and linked mental health data from adolescents in schools: protocol co-production and a mixed-methods pilot of feasibility and acceptability. BMJ Open 12 (2) e049283. (10.1136/bmjopen-2021-049283)
- Wong, H. S. et al., 2020. Pilot study to establish a prospective neonatal cohort: Study of Preterm Infants and Neurodevelopmental Genes (SPRING). Molecular Psychiatry 4 (1) e000648. (10.1136/bmjpo-2020-000648)
- Legge, S. et al. 2020. Clinical indicators of treatment-resistant psychosis. British Journal of Psychiatry 216 (5), pp.259-266. (10.1192/bjp.2019.120)
- Harold, D. et al., 2019. Population-based identity-by-descent mapping combined with exome sequencing to detect rare risk variants for schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 180 (3), pp.223-231. (10.1002/ajmg.b.32716)
- Cosgrove, D. et al., 2017. MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls. Translational Psychiatry 7 (1), pp.e1012. (10.1038/tp.2016.286)
Contact Details
[email protected]
+44 29206 88365
Adeilad Hadyn Ellis, Ystafell 2.54, Heol Maendy, Caerdydd, CF24 4HQ
+44 29206 88365
Adeilad Hadyn Ellis, Ystafell 2.54, Heol Maendy, Caerdydd, CF24 4HQ